Received: June 25, 2002
From: Atsushi Takeshita <
[email protected]>
DoCoMo USA Labs� patent statement pertaining to a number of
Internet-Drafts (listed) in claim
* DoCoMo Communications laboratories USA, Inc. (DoCoMo USA Labs) will
not assert its US provisional Patent No. 60/358,177 ("Securing MIPv6
BINDING UPDATES USING ADDRESS BASED KEYS (ABK)"), its US non-provisional
patent or its non-US counterpart against any party that implements
draft-okazaki-mobileip-abk-00.txt or any derivative, when this is employed
as a standard.
* DoCoMo Communications laboratories USA, Inc. (DoCoMo USA Labs) will
not assert its US provisional Patent No. 60/358,286 ("Securing MIPv6 IPv6
NEIGHBOR DISCOVERY USING ADDRESS BASED KEYS (ABK)"), its US non-
provisional patent or its non-US counterpart against any party that
implements draft-kempf-secure-nd-02.txt or any derivative, when this is
employed as a standard.
* DoCoMo Communications laboratories USA, Inc. (DoCoMo USA Labs) will
not assert its US provisional Patent "Link-layer Triggers Protocol" (June
19, 2002), its US non-provisional patent or its non-US counterpart against
any party that implements draft-yegin-l2-triggers-00.txt or any
derivative, when this is employed as a standard.
* DoCoMo Communications laboratories USA, Inc. (DoCoMo USA Labs) will
not assert its US provisional Patent "Low latency mobile initiated tunneling
handoff" (May 3, 2002), its US non-provisional patent or its non-US counterpart against any party that implements draft-gwon-mobileip-postmithv6-00.txt or any derivative, when this is employed as a standard.
Each grant of rights will terminate with respect to any party that asserts a
patent it owns, directly or indirectly, against DoCoMo USA Labs and affiliates for
their implementation of and operation in compliance with each Internet Draft or any derivative. This termination will occur as of the date the patent is asserted against DoCoMo USA Labs and affiliates.
With best regards,
Atsushi Takeshita
Senior Vice President, Executive Director
DoCoMo Communications Laboratories USA, Inc.
181 Metro Drive, Suite 300
San Jose, CA 95110
[email protected]
Tel: +1-408-451-4705
FAX: +1-408-573-1090